Skip to content
All news
Earnings

Fastenal Q2 Earnings Meet Estimates, Sales Beat on Favorable Pricing

Fastenal (FAST) reported Q2 2025 earnings in line with estimates, while revenue beat expectations driven by contract customer growth and digital sales momentum. However, margin pressures and weaker cash flow weighed on the stock.

July 14, 2026
2 min read
Source: Zacks
Share:

Key Numbers

revenue
1.92B
eps
0.52
contract customer growth
5.2%
digital sales growth
12.1%

Fastenal Company (NASDAQ: FAST) reported second-quarter 2025 results, with revenue of $1.92 billion beating analyst estimates, while earnings per share (EPS) of $0.52 matched expectations. The stock edged slightly higher in after-hours trading.

Key Financial Results

MetricQ2 2025vs. Q2 2024
Revenue$1.92B+4.5%
Net Income$298M+3.2%
EPS$0.52+4.0%

Highlights from the Report

  • Contract customer growth: Increased 5.2% year-over-year.
  • Digital sales: Grew 12.1%, driven by higher adoption of e-commerce platforms.
  • Margin pressure: Gross margin contracted 30 basis points due to rising raw material costs.
  • Cash flow: Free cash flow declined 8% compared to the prior-year quarter.

Guidance

The company did not provide specific numerical guidance for Q3, but indicated continued investment in digital capabilities and customer base expansion.

Stock Impact

Despite the revenue beat, margin pressures and weaker cash flow limited stock gains. The stock is currently trading at $68, up 0.5% after the announcement.

What This Means for Investors

Fastenal's results reflect strong demand in the industrial distribution sector, but cost pressures remain a concern. Investors should monitor the company's ability to improve margins and sustain digital sales growth.

Frequently Asked Questions

Fastenal's revenue was $1.92 billion in Q2 2025, beating analyst expectations.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.